SCHEMBL12440313

SCHEMBL12440313

CN1CCN(c2ccnc(-c3cncc(-c4cc(-c5ccccc5F)nc5ncccc45)c3)n2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 8/20 0.53
ALDH1A1 P00352 7/20 0.53
CYP3A4 P08684 6/20 0.53
CYP2D6 P10635 5/20 0.53
HSD17B10 Q99714 4/20 0.53
CLK4 Q9HAZ1 3/20 0.53
TSHR P16473 2/20 0.53
CYP2C19 P33261 3/20 0.46
USP2 O75604 3/20 0.46
KDM4E B2RXH2 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
ALOX15 P16050 2/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
HRH4 Q9H3N8 2/20 0.37
LMNA P02545 1/20 0.37
MAPK14 Q16539 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12440069 0.90 CYP1A2 (0.46) CYP1A2ALDH1A1CYP3A4CYP2D6HSD17B10
SCHEMBL19791404 0.85 MAP4K1 (0.42) CYP1A2CYP3A4CYP2D6CLK4ALOX15
SCHEMBL12440312 0.85 GBA1 (0.45) CYP1A2ALDH1A1CYP3A4CYP2D6HSD17B10
SCHEMBL2324592 0.84 LMNA (0.36) CYP1A2ALDH1A1CYP3A4CYP2D6HSD17B10
SCHEMBL12440009 0.80 ALDH1A1 (0.38) CYP1A2ALDH1A1CYP3A4CYP2D6HSD17B10
SCHEMBL2328864 0.80 TNKS (0.45) HRH4MAPK14CSNK1DPIM1PIM3
SCHEMBL13834756 0.79 TDO2 (0.45) CLK4MAPK14CSNK1DMET
SCHEMBL2324168 0.78 ALK (0.42) CLK4MET
SCHEMBL2326924 0.78 CNR2 (0.45) TSHRKDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL12441212 0.78 NPC1 (0.39) CYP1A2ALDH1A1CYP3A4CYP2D6HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2531500-B1 HETARYL-[1,8]NAPHTHYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2018-01-24 EP disclosed
EP-2531500-B1 HETARYL-[1,8]NAPHTHYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2018-01-24 EP disclosed
US-8912216-B2 Hetaryl-[1,8]naphthyridine derivatives MERCK PATENT GMBH (DE) 2014-12-16 US disclosed
US-8912216-B2 Hetaryl-[1,8]naphthyridine derivatives MERCK PATENT GMBH (DE) 2014-12-16 US disclosed
US-8912216-B2 Hetaryl-[1,8]naphthyridine derivatives MERCK PATENT GMBH (DE) 2014-12-16 US disclosed
US-20140038960-A1 Hetaryl-[1,8]naphthyridine derivatives MERCK PATENT GMBH (DE) 2014-02-06 US disclosed
US-20140038960-A1 Hetaryl-[1,8]naphthyridine derivatives MERCK PATENT GMBH (DE) 2014-02-06 US disclosed
US-20140038960-A1 Hetaryl-[1,8]naphthyridine derivatives MERCK PATENT GMBH (DE) 2014-02-06 US disclosed
US-8614226-B2 Hetaryl-[1,8]naphthyridine derivatives MERCK PATENT GMBH (DE) 2013-12-24 US disclosed
US-20120295902-A1 Hetaryl-[1,8]naphthyridine derivatives MERCK PATENT GMBH (DE) 2012-11-22 US disclosed
US-20120295902-A1 Hetaryl-[1,8]naphthyridine derivatives MERCK PATENT GMBH (DE) 2012-11-22 US disclosed
US-20120295902-A1 Hetaryl-[1,8]naphthyridine derivatives MERCK PATENT GMBH (DE) 2012-11-22 US disclosed
WO-2011095196-A1 HETARYL-[1,8]NAPHTHYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2011-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140038960-A1 Hetaryl-[1,8]naphthyridine derivatives ATP5F1A, ATP5ME, ATP5F1D CYP1A2 322/4885ALDH1A1 1429/4885CYP3A4 682/4885
US-20120295902-A1 Hetaryl-[1,8]naphthyridine derivatives ATP5F1A, ATP5ME, ATP5F1D CYP1A2 322/4885ALDH1A1 1429/4885CYP3A4 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.